With all buzz around AI and the role it could play in clinical trial recruitment, there are still limitations. Spreading awareness is one such limitation. Research shows many clinical trials fail to recruit simply because patients are unaware clinical trials are even an option. Low awareness also tends to disproportionately affect minority groups with the FDA reporting that only 8% of participants in US based clinical trials are African-American compared to 13% of the total population. GoodLab Clinical Trials continues to close the Awareness Gap and buck this trend with close to 30% of it's users African-American through the month of May - more than twice the general population.
May was another bumper month for GoodLab. We had a diverse audience of close to 500,000 people register their interest in clinical trials. These participants selected from over 120 trials across 15+ therapeutic areas. Our "spotlight trial" was with our long time partner Citeline Clinical where we helped drive 4 screens (20% screen rate!) to a very difficult trial seeking individuals who have received a liver or lung transplant and are receiving chronic immunosuppressive therapy. So far in June we have already had 400k+ register for trials - if you want to get in front of these individuals please reach out.
Barrister at 5 Wentworth Chambers
4moKeep up the good work!